Tatsunori Shimoi

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

British journal of cancer

Cancers

Journal of gynecologic oncology

Cancer science

Ministry of Health, Labour and Welfare

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ministry of Health, Labour and Welfare Apr 10 2017

Japan

Assistant Director :: Health Insurance Bureau Medical Economics Division

National Cancer Center Hospital Apr 01 2012

Japan

Medical Staff :: Breast and Medical Oncology

Publications

Masaki Uchihara, Akiyo Tanabe, Yuki Kojima, Tatsunori Shimoi, Akiko Miyagi Maeshima, Kotaro Umamoto, Akihiko Shimomura, Chikako Shimizu, Yuto Yamazaki, Eijiro Nakamura, Yoshiyuki Matsui, Nobuyuki Takemura, Hideyo Miyazaki, Kazuki Sudo, Kan Yonemori, Hiroshi Kajio
Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma. Cancers 16 (12) (2024)
Masaki Uchihara, Akiyo Tanabe, Yuki Kojima, Tatsunori Shimoi, Akiko Miyagi Maeshima, Kotaro Umamoto, Akihiko Shimomura, Chikako Shimizu, Yuto Yamazaki, Eijiro Nakamura, Yoshiyuki Matsui, Nobuyuki Takemura, Hideyo Miyazaki, Kazuki Sudo, Kan Yonemori, Hiroshi Kajio
Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma. Cancers 16 (12) (2024)
Rui Kitadai, Tatsunori Shimoi, Shu Yazaki, Hitomi Sumiyoshi Okuma, Mai Hoshino, Munehiro Ito, Ayumi Saito, Shosuke Kita, Yuki Kojima, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Yasuhiro Fujiwara, Masayuki Yoshida, Kan Yonemori
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine. Breast cancer (Tokyo, Japan) (2024)
Risako Ozawa, Tadaaki Nishikawa, Hiroshi Yoshida, Kouya Shiraishi, Tatsunori Shimoi, Tomoyasu Kato, Kan Yonemori
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers. Journal of gynecologic oncology (2024)
Takafumi Koyama, Toshio Shimizu, Yuki Kojima, Kazuki Sudo, Hitomi Sumiyoshi Okuma, Tatsunori Shimoi, Hitotshi Ichikawa, Shinji Kohsaka, Ryo Sadachi, Akihiro Hirakawa, Akihiko Yoshida, Reiko Makihara Ando, Toshihide Ueno, Mitsuru Yanagaki, Naoko Matsui, Kenichi Nakamura, Noboru Yamamoto, Kan Yonemori
Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase 1b/2 study. Cancer discovery (2023)
Takaki Omura, Masamichi Takahashi, Makoto Ohno, Yasuji Miyakita, Shunsuke Yanagisawa, Yukie Tamura, Miyu Kikuchi, Daisuke Kawauchi, Tomoyuki Nakano, Tomohiro Hosoya, Hiroshi Igaki, Kaishi Satomi, Akihiko Yoshida, Kuniko Sunami, Makoto Hirata, Tatsunori Shimoi, Kazuki Sudo, Hitomi S Okuma, Kan Yonemori, Hiromichi Suzuki, Koichi Ichimura, Yoshitaka Narita
Clinical Application of Comprehensive Genomic Profiling Tests for Diffuse Gliomas. Cancers 14 (10) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Yuki Kojima, Hiroshi Yoshida, Shigemasa Takamizawa, Rui Kitadai, Tadaaki Nishikawa, Tatsunori Shimoi, Kazuki Sudo, Ayumi Saito, Hitomi Sumiyoshi Okuma, Maki Tanioka, Emi Noguchi, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Yasuhiro Fujiwara, Yuichiro Ohe, Kan Yonemori
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer. Journal of gynecologic oncology 33 (6) (2022)
Shu Yazaki, Tatsunori Shimoi, Masayuki Yoshida, Hitomi Sumiyoshi-Okuma, Motoko Arakaki, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Sho Shiino, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Yasuhiro Fujiwara, Kan Yonemori
Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy. Breast cancer research and treatment (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Chikashi Watase, Sho Shiino, Tatsunori Shimoi, Emi Noguchi, Tomoya Kaneda, Yusuke Yamamoto, Kan Yonemori, Shin Takayama, Akihiko Suto
Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives. Cancers 13 (5) (2021)
Tatsunori Shimoi, Emi Noguchi, Kazuki Sudo, Yu Jo Chua, Kan Yonemori
Critical Appraisal of Adjuvant Platinum-Based Chemotherapy for Basal Subtype Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Tatsunori Shimoi, Yasuaki Sagara, Fumikata Hara, Tatsuya Toyama, Hiroji Iwata
First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis. Breast cancer (Tokyo, Japan) 27 (3) (2020)
Seiko Bun, Mayu Yunokawa, Takahiro Ebata, Mayumi Kobayashi Kato, Tatsunori Shimoi, Tomoyasu Kato, Kenji Tamura
Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study. International journal of clinical oncology 24 (9) (2019)
Chihiro Udagawa, Hiromi Nakamura, Hiroshi Ohnishi, Kenji Tamura, Tatsunori Shimoi, Masayuki Yoshida, Teruhiko Yoshida, Yasushi Totoki, Tatsuhiro Shibata, Hitoshi Zembutsu
Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity. Cancer science 109 (2) (2018)
Tatsunori Shimoi, Akinobu Hamada, Marifu Yamagishi, Mitsuharu Hirai, Masayuki Yoshida, Tadaaki Nishikawa, Kazuki Sudo, Akihiko Shimomura, Emi Noguchi, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Takahiro Fukuda, Yasuhiro Fujiwara, Kenji Tamura
PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system. Cancer science 109 (8) (2018)
Sakura Iizumi, Tatsunori Shimoi, Natsuko Tsushita, Seiko Bun, Akihiko Shimomura, Emi Noguchi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara, Kenji Tamura
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study. BMC cancer 17 (1) (2017)

Tatsunori Shimoi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tatsunori Shimoi